Use of Thiazides to Treat Hypertension and Advanced CKD

Gargi Sharma Priamvada1, Divya Sharma Divyadarshini2, Raven Voora3

  • 1Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, NC, USA.

Insights

Thiazide diuretics, like chlorthalidone, effectively lower blood pressure in advanced chronic kidney disease (CKD). Recent data challenge previous beliefs about their inefficacy, but careful patient monitoring is essential.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Hypertension management in chronic kidney disease (CKD) is challenging, with many patients experiencing suboptimal blood pressure control.
  • The use of thiazide diuretics in advanced CKD has been historically limited due to concerns about their reduced efficacy at lower glomerular filtration rates (GFR).

Purpose of the Study:

  • To review recent evidence on the efficacy and safety of thiazide diuretics in patients with CKD.
  • To discuss the mechanisms by which thiazides exert their blood pressure-lowering effects in this population.
  • To address the current indications for thiazide use in advanced CKD.

Main Methods:

  • Review of recent clinical trials and observational studies.
  • Analysis of pharmacological mechanisms of thiazide action.
  • Synthesis of current guidelines and expert opinions.

Main Results:

  • Recent clinical trial data demonstrate that thiazide diuretics, such as chlorthalidone, are effective in reducing blood pressure in patients with advanced CKD.
  • These findings challenge the long-held belief that thiazides lose their efficacy at lower GFR levels.
  • Electrolyte and kidney function monitoring are crucial for ensuring patient safety when using thiazides in CKD.

Conclusions:

  • Thiazide diuretics can be safely and effectively used for blood pressure management in patients with advanced CKD.
  • Further research may refine optimal dosing and monitoring strategies for thiazides in this patient group.
  • Clinicians should consider thiazides as a viable option for hypertension control in CKD, with appropriate precautions.
Abstract

Related Concept Videos

Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
816
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
454
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
70
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
696
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
42
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
56